EirGenix Inc. (TPEX:6589)
62.10
-0.70 (-1.11%)
Jun 13, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Biopharmaceuticals | 1.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceuticals Growth | -1.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Japan | 359.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | 92.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Taiwan | 338.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Taiwan Growth | -28.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States and Canada | 165.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States and Canada Growth | 39.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 143.87M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | -40.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hong Kong, Macau and China | 1.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hong Kong, Macau and China Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|